EXPERIMENTAL DRUG YIELDS DRAMATIC WEIGHT LOSS

Summary from the TLDR newsletter

Retatrutide, an experimental shot by drugmaker Eli Lilly, was so powerful in human trials that participants stopped taking it because they thought they were losing too much weight. The results for some of the heaviest patients were on par with those seen with gastric bypass surgery. There are some side effects at higher doses, such as gastrointestinal side effects so unpleasant that some patients stop taking it. Eli Lilly has not yet applied for regulatory approval.